Eurofins Transplant Genomics
UEI: QGB2L5JWUQF9
• CAGE: 9RRZ6
Overview
Parent Awardee
Company Description
Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy.
Name
Eurofins Transplant Genomics
Website
Headquarters
Lenexa, KS
United States
United States
Most Recent Award
April 1, 2026
Calculating
Federal contract recipient
EUROFINS TRANSPLANT GENOMICS, LLC
(UEI QGB2L5JWUQF9, CAGE 9RRZ6)
is headquartered in Lenexa KS.
Its primary registered NAICS is 621511 Medical Laboratories.
The corporation
was founded in March 2013 and
federally registered in
August 2023.
Federal Award Analysis
Eurofins Transplant Genomics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
EUROFINS TRANSPLANT GENOMICS, LLC
UEI
QGB2L5JWUQF9
CAGE Code
9RRZ6
Primary NAICS
SBA Certifications
None
Self Certifications
Foreign Owned, For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 21, 2013
Initial Registration
Aug. 14, 2023
Last Registration
Sept. 9, 2025
Registration Activation
Sept. 9, 2025
Registration Expiration
Sept. 3, 2026
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes